| Literature DB >> 28680348 |
Gabriel Lima-Oliveira1,2,3, Gian Cesare Guidi1, Andre Valpassos Pacifici Guimaraes2,3, Jose Abol Correa3, Giuseppe Lippi1.
Abstract
BACKGROUND: The multifaceted clinical laboratory process is divided in three essential phases: the preanalytical, analytical and postanalytical phase. Problems emerging from the preanalytical phase are responsible for more than 60% of laboratory errors. This report is aimed at highlighting and discussing nonconformity (e.g., nonstandardized procedures) in primary blood tube mixing immediately after blood collection by venipuncture with evacuated tube systems.Entities:
Keywords: accreditation; blood specimen collection; phlebotomy; quality; specimen handling
Year: 2017 PMID: 28680348 PMCID: PMC5471658 DOI: 10.1515/jomb-2016-0032
Source DB: PubMed Journal: J Med Biochem ISSN: 1452-8266 Impact factor: 3.402
Objective evidence from nonconformity reports regarding primary blood tube mixing immediately after blood collection by venipuncture, as reported by 50 Brazilian clinical laboratories during their internal audit processes.
| Objective evidence | Frequency |
|---|---|
| Evacuated blood tubes were left in upright position and sent to core laboratory without mixing afterwards. | 2/50 (4%) |
| Evacuated blood tubes were shaken up vigorously immediately after appropriate filling, independently of the additive type inside the tubes. | 30/50 (60%) |
| Evacuated blood tubes were mixed gently and carefully by inverting but the number of times was different from that recommended by the manufacturer. | 44/50 (88%) |
neither hemolyzed nor clotted samples (including no fibrin filaments or micro clots) due to this kind of mixing procedure were reported by the evaluated laboratories. This observation is in line with outcomes from Parenmark and Landberg (8), and Lima-Oliveira et al. (10).
Mixing recommendation from the manufacturers of evacuated tubes used by the laboratories audited.
| Tube description | Mix recommendation by manufacturers | |
|---|---|---|
| Becton Dickinson® | Greiner Bio-one® | |
| without additive | – | from 5 to 10 |
| with sodium citrate | from 3 to 4 | from 4 to 5 |
| with clot activator | 6 | from 5 to 10 |
| with heparin | from 8 to 10 | from 5 to 10 |
| with EDTA | from 8 to 10 | from 5 to 10 |
| with glycolysis inhibitor | from 8 to 10 | from 5 to 10 |
EDTA, ethylenediaminetetraacetic acid;
mix the blood gently and thoroughly by inverting the tube for the required number of inversions as specified in the manufacturer’s instructions.